PharmaCorp Announces Executive Transition and New Director of Business Development
SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. ("PharmaCorp" or the "Corporation") (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Officer, effective Decemb
(Financial Post, 2025-11-29T00:30:45Z)